Sundrug Co.,Ltd. (TYO:9989)
Japan
· Delayed Price · Currency is JPY 4,414.00
-30.00 (-0.68%)
Jun 6, 2025, 3:30 PM JST
Sundrug Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Revenue | 801,811 | 751,777 | 690,462 | 648,734 | 634,310 | Upgrade
|
| Revenue Growth (YoY) | 6.65% | 8.88% | 6.43% | 2.27% | 2.68% | Upgrade
|
| Cost of Revenue | 597,723 | 562,457 | 518,516 | 492,228 | 475,760 | Upgrade
|
| Gross Profit | 204,088 | 189,320 | 171,946 | 156,506 | 158,550 | Upgrade
|
| Selling, General & Admin | 142,305 | 133,294 | 134,492 | 122,454 | 120,879 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 325 | Upgrade
|
| Operating Expenses | 159,587 | 148,323 | 134,495 | 122,454 | 121,204 | Upgrade
|
| Operating Income | 44,501 | 40,997 | 37,451 | 34,052 | 37,346 | Upgrade
|
| Interest Expense | -164 | -32 | -36 | -9 | -6 | Upgrade
|
| Interest & Investment Income | 160 | 127 | 125 | 128 | 130 | Upgrade
|
| Earnings From Equity Investments | -1,567 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 904 | 636 | 594 | 563 | 758 | Upgrade
|
| EBT Excluding Unusual Items | 43,834 | 41,728 | 38,134 | 34,734 | 38,228 | Upgrade
|
| Gain (Loss) on Sale of Investments | 198 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -6 | 21 | 144 | 232 | 119 | Upgrade
|
| Asset Writedown | -998 | -856 | -864 | -282 | -375 | Upgrade
|
| Other Unusual Items | 541 | 367 | 296 | -10 | -784 | Upgrade
|
| Pretax Income | 43,569 | 41,260 | 37,710 | 34,674 | 37,188 | Upgrade
|
| Income Tax Expense | 12,819 | 12,134 | 12,007 | 10,821 | 11,859 | Upgrade
|
| Net Income | 30,750 | 29,126 | 25,703 | 23,853 | 25,329 | Upgrade
|
| Net Income to Common | 30,750 | 29,126 | 25,703 | 23,853 | 25,329 | Upgrade
|
| Net Income Growth | 5.58% | 13.32% | 7.76% | -5.83% | 6.91% | Upgrade
|
| Shares Outstanding (Basic) | 117 | 117 | 117 | 117 | 117 | Upgrade
|
| Shares Outstanding (Diluted) | 117 | 117 | 117 | 117 | 117 | Upgrade
|
| Shares Change (YoY) | 0.02% | 0.01% | 0.01% | 0.00% | 0.02% | Upgrade
|
| EPS (Basic) | 262.90 | 249.06 | 219.83 | 204.02 | 216.67 | Upgrade
|
| EPS (Diluted) | 262.90 | 249.06 | 219.82 | 204.01 | 216.63 | Upgrade
|
| EPS Growth | 5.56% | 13.30% | 7.75% | -5.83% | 6.89% | Upgrade
|
| Free Cash Flow | 7,713 | 4,762 | 12,591 | 12,857 | 15,944 | Upgrade
|
| Free Cash Flow Per Share | 65.94 | 40.72 | 107.68 | 109.96 | 136.37 | Upgrade
|
| Dividend Per Share | 130.000 | 114.000 | 100.000 | 71.000 | 70.000 | Upgrade
|
| Dividend Growth | 14.04% | 14.00% | 40.84% | 1.43% | 2.94% | Upgrade
|
| Gross Margin | 25.45% | 25.18% | 24.90% | 24.13% | 25.00% | Upgrade
|
| Operating Margin | 5.55% | 5.45% | 5.42% | 5.25% | 5.89% | Upgrade
|
| Profit Margin | 3.84% | 3.87% | 3.72% | 3.68% | 3.99% | Upgrade
|
| Free Cash Flow Margin | 0.96% | 0.63% | 1.82% | 1.98% | 2.51% | Upgrade
|
| EBITDA | 61,783 | 56,124 | 49,519 | 44,261 | 46,009 | Upgrade
|
| EBITDA Margin | 7.70% | 7.47% | 7.17% | 6.82% | 7.25% | Upgrade
|
| D&A For EBITDA | 17,282 | 15,127 | 12,068 | 10,209 | 8,663 | Upgrade
|
| EBIT | 44,501 | 40,997 | 37,451 | 34,052 | 37,346 | Upgrade
|
| EBIT Margin | 5.55% | 5.45% | 5.42% | 5.25% | 5.89% | Upgrade
|
| Effective Tax Rate | 29.42% | 29.41% | 31.84% | 31.21% | 31.89% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.